NL6805288A - - Google Patents

Info

Publication number
NL6805288A
NL6805288A NL6805288A NL6805288A NL6805288A NL 6805288 A NL6805288 A NL 6805288A NL 6805288 A NL6805288 A NL 6805288A NL 6805288 A NL6805288 A NL 6805288A NL 6805288 A NL6805288 A NL 6805288A
Authority
NL
Netherlands
Application number
NL6805288A
Other versions
NL156700B (nl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL6805288A publication Critical patent/NL6805288A/xx
Publication of NL156700B publication Critical patent/NL156700B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576Six-membered rings
    • C07F9/58Pyridine rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
NL6805288.A 1967-04-14 1968-04-11 Werkwijze voor het bereiden van een preparaat met psychotrope werking op basis van een 7-gesubstitueerd-4-(4-pyridyl)-2h-chromeenderivaat, gevormd preparaat, alsmede werkwijze voor het bereiden van de daarin gebruikte psychotroop werkzame verbinding. NL156700B (nl)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US63080867A 1967-04-14 1967-04-14
US3646670A 1970-05-11 1970-05-11
US59854A US3707474A (en) 1967-04-14 1970-06-26 Certain 4-(4-pyridyl)-5-hydroxy-coumarin intermediates
US00151578A US3726883A (en) 1967-04-14 1971-06-09 2,2-di-and 2,2,3-tri-lower alkyl chroman-and chromen-ols and salts,ethers and esters thereof
US00300443A US3847928A (en) 1967-04-14 1972-10-25 Certain ethers,esters or non-toxic acid addition salt derivatives of 2,2-di-and 2,2,3-tri-lower alkyl chroman-and chromen-ols

Publications (2)

Publication Number Publication Date
NL6805288A true NL6805288A (fi) 1968-10-15
NL156700B NL156700B (nl) 1978-05-16

Family

ID=27534589

Family Applications (2)

Application Number Title Priority Date Filing Date
NL6805288.A NL156700B (nl) 1967-04-14 1968-04-11 Werkwijze voor het bereiden van een preparaat met psychotrope werking op basis van een 7-gesubstitueerd-4-(4-pyridyl)-2h-chromeenderivaat, gevormd preparaat, alsmede werkwijze voor het bereiden van de daarin gebruikte psychotroop werkzame verbinding.
NL7106410A NL7106410A (fi) 1967-04-14 1971-05-10

Family Applications After (1)

Application Number Title Priority Date Filing Date
NL7106410A NL7106410A (fi) 1967-04-14 1971-05-10

Country Status (9)

Country Link
US (3) US3707474A (fi)
AT (1) AT305281B (fi)
BE (2) BE713490A (fi)
CH (3) CH499541A (fi)
CY (1) CY665A (fi)
DE (2) DE1770171C3 (fi)
FR (2) FR1559520A (fi)
GB (2) GB1162784A (fi)
NL (2) NL156700B (fi)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE713490A (fi) * 1967-04-14 1968-10-10
BE757454R (fr) * 1969-10-15 1971-04-13 Beecham Group Ltd Composes organiques derivant de pyridylbenzopyrannes, composes intermediaires et procedes pour les
BE758329A (fr) * 1969-10-31 1971-04-30 Beecham Group Ltd Procede de preparation de benzopyranne-5-ols et des coumarines intermediaires en passant par de nouveaux beta- cetoesters
GB1314427A (en) * 1970-07-17 1973-04-26 Beecham Group Ltd Amino acid esters of 2,2-dialkyl-4-4-pyridyl-2h-7-substituted- chromen-5-ols
BE794630A (fr) * 1972-01-26 1973-07-26 Beecham Group Ltd Composes polycycliques antihypertenseurs
US3960880A (en) * 1974-03-26 1976-06-01 Beecham Group Limited Tetrahydropyrid-4-yl-chroman-5-ol derivatives
US3973023A (en) * 1972-01-26 1976-08-03 Beecham Group Limited Anti-hypertensive polycyclic compounds for treating hypertension
GB1417745A (en) * 1973-07-07 1975-12-17 Beecham Group Ltd Chromene compounds
US3947462A (en) * 1974-05-22 1976-03-30 Abbott Laboratories 2,4,7-substituted 5-hydroxy benzopyrans and esters
US5284838A (en) * 1987-06-23 1994-02-08 Elf Sanofi Use of 2,2-dimethylchroman-3-ol derivatives in the treatment of asthma
DE3837809A1 (de) * 1988-11-08 1990-05-10 Merck Patent Gmbh Tetralinderivate
DE3924417A1 (de) * 1989-07-24 1991-01-31 Merck Patent Gmbh Chromanderivate
EP1802298B1 (en) * 2004-10-22 2008-12-31 DSMIP Assets B.V. Novel agents for preventing and treating disorders connected to impaired neurotransmission
WO2009150668A1 (en) * 2008-06-13 2009-12-17 Delhi University Dihydropyridimidinone compounds for the treatment of cardiovascular diseases and process for preparing the same
US20110178168A1 (en) * 2008-06-23 2011-07-21 Virender Singh Parmar Coumarin compounds for the treatment of cardiovascular diseases and a process for preparing the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3311636A (en) * 1963-03-14 1967-03-28 Upjohn Co Organic chemical compounds and process
BE713490A (fi) * 1967-04-14 1968-10-10

Also Published As

Publication number Publication date
US3707474A (en) 1972-12-26
CH554365A (de) 1974-09-30
FR1559520A (fi) 1969-03-07
CH499541A (de) 1970-11-30
CY665A (en) 1972-12-09
DE1770171C3 (de) 1979-08-30
CH556355A (de) 1974-11-29
DE1770171A1 (de) 1971-09-23
US3726883A (en) 1973-04-10
FR2100643A1 (fi) 1972-03-24
NL7106410A (fi) 1971-11-15
AT305281B (de) 1973-02-26
US3847928A (en) 1974-11-12
DE1770171B2 (de) 1978-12-21
NL156700B (nl) 1978-05-16
FR2100643B1 (fi) 1975-04-18
GB1162784A (en) 1969-08-27
GB1314428A (en) 1973-04-26
DE2122643A1 (de) 1971-11-25
BE713490A (fi) 1968-10-10
BE766890A (fr) 1971-11-08

Similar Documents

Publication Publication Date Title
AU425114B2 (fi)
FR2100643B1 (fi)
AU416737B2 (fi)
AU610966A (fi)
BE692779A (fi)
BE692553A (fi)
BE711711A (fi)
BE711340A (fi)
BE710653A (fi)
BE609934A (fi)
BE709653A (fi)
BE709471A (fi)
BE709223A (fi)
BE708847A (fi)
BE704023A (fi)
BE703815A (fi)
AU34866A (fi)
BE703133A (fi)
BE698128A (fi)
BE696163A (fi)
BE692780A (fi)
BE614676A (fi)
BE692778A (fi)
BE692654A (fi)
BE692577A (fi)

Legal Events

Date Code Title Description
V1 Lapsed because of non-payment of the annual fee
NL80 Information provided on patent owner name for an already discontinued patent

Owner name: BEECHAN